| ATAI Life Sciences AG |
|
0 |
6905774 |
0 |
6905774 |
6905774 |
10.1 % |
27/09/2024 |
| ATAI Life Sciences N.V. |
|
0 |
6905774 |
0 |
6905774 |
6905774 |
10.1 % |
27/09/2024 |
| Group Funding (ECI) (U) LLC |
Delaware |
0 |
10796736 |
0 |
10796736 |
10796736 |
6.7 % |
01/03/2022 |
| Group Investments LLC |
Delaware |
0 |
10796736 |
0 |
10796736 |
10796736 |
6.7 % |
01/03/2022 |
| E. Novogratz |
Delaware |
0 |
10796736 |
0 |
10796736 |
10796736 |
6.7 % |
01/03/2022 |
| Apeiron Investment Group Ltd. |
|
0 |
32059504 |
0 |
32059504 |
32059504 |
19.7 % |
10/02/2022 |
| Apeiron Presight Capital Fund II, L.P. |
|
0 |
1187104 |
0 |
1187104 |
1187104 |
0.7 % |
10/02/2022 |
| Presight Capital Management I, L.L.C. |
|
0 |
1187104 |
0 |
1187104 |
1187104 |
0.7 % |
10/02/2022 |
| Fabian Hansen |
|
0 |
1187104 |
0 |
1187104 |
1187104 |
0.7 % |
10/02/2022 |
| Christian Angermayer |
|
0 |
32059504 |
0 |
32059504 |
32059504 |
19.7 % |
10/02/2022 |
| ATAI Life Sciences AG |
|
0 |
9435758 |
0 |
9435758 |
9435758 |
22.6 % |
01/12/2021 |
| ATAI Life Sciences N.V. |
|
0 |
9435758 |
0 |
9435758 |
9435758 |
22.6 % |
01/12/2021 |
| ATAI Life Sciences N.V. |
|
0 |
8694758 |
0 |
8694758 |
8694758 |
20.8 % |
29/11/2021 |
| ATAI Life Sciences AG |
|
0 |
8694758 |
0 |
8694758 |
8694758 |
20.8 % |
29/11/2021 |
| ATAI Life Sciences BV |
|
0 |
8075663 |
0 |
8075663 |
8075663 |
19.7 % |
24/05/2021 |
| ATAI Life Sciences AG |
|
0 |
8075663 |
0 |
8075663 |
8075663 |
19.7 % |
24/05/2021 |
| ATAI Life Sciences AG |
|
0 |
233680000 |
0 |
11 |
233680000 |
67.6 % |
24/05/2021 |
| ATAI Life Sciences B.V. |
|
0 |
233680000 |
0 |
11 |
233680000 |
67.6 % |
24/05/2021 |